Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Extracts from "Clinical Evidence". Obesity.

× No keyword cloud information.

40 in total

1. Caution when using oral contraceptive pills with Orlistat.

Authors: R Peleg
Journal: Isr Med Assoc J Date: 2000-09 Impact factor: 0.892

2. The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study.

Authors: F Lindgärde
Journal: J Intern Med Date: 2000-09 Impact factor: 8.989

3. Annual deaths attributable to obesity in the United States.

Authors: D B Allison; K R Fontaine; J E Manson; J Stevens; T B VanItallie
Journal: JAMA Date: 1999-10-27 Impact factor: 56.272

4. The spread of the obesity epidemic in the United States, 1991-1998.

Authors: A H Mokdad; M K Serdula; W H Dietz; B A Bowman; J S Marks; J P Koplan
Journal: JAMA Date: 1999-10-27 Impact factor: 56.272

5. Delayed onset of pulmonary hypertension associated with an appetite suppressant, mazindol: a case report.

Authors: M Hagiwara; A Tsuchida; M Hyakkoku; K Nishizato; T Asai; Y Nozawa; K Tsuchihashi; K Shimamoto
Journal: Jpn Circ J Date: 2000-03

6. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial.

Authors: F G McMahon; K Fujioka; B N Singh; C M Mendel; E Rowe; K Rolston; F Johnson; A D Mooradian
Journal: Arch Intern Med Date: 2000-07-24

Review 7. Scientific and legal issues in fenfluramine/dexfenfluramine litigation.

Authors: W S Poston; J P Foreyt
Journal: Tex Med Date: 2000-02

8. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.

Authors: N Finer; W P James; P G Kopelman; M E Lean; G Williams
Journal: Int J Obes Relat Metab Disord Date: 2000-03

9. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.

Authors: J M Gardin; D Schumacher; G Constantine; K D Davis; C Leung; C L Reid
Journal: JAMA Date: 2000-04-05 Impact factor: 56.272

10. Orlistat in the long-term treatment of obesity in primary care settings.

Authors: J Hauptman; C Lucas; M N Boldrin; H Collins; K R Segal
Journal: Arch Fam Med Date: 2000-02

5 in total

Review 1. Management of overweight and obese adults.

Authors: Polly Hitchcock Noël; Jacqueline A Pugh
Journal: BMJ Date: 2002-10-05

2. Anthropometric Parameters of Armed Forces Personnel.

Authors: R Vaidya; R Bhalwar; S Bobdey
Journal: Med J Armed Forces India Date: 2011-07-21

Review 3. Pharmacotherapy for obesity.

Authors: Lisa L Ioannides-Demos; Joseph Proietto; John J McNeil
Journal: Drugs Date: 2005 Impact factor: 9.546

4. Acupoint catgut embedding for obesity: A protocol of systematic review.

Authors: Wei Huang; Xia Chen; Yanji Zhang; Lihua Wang; Jiajie Wang; Yingrong Zhang; Dan Wei; Zhongyu Zhou
Journal: Medicine (Baltimore) Date: 2020-12-18 Impact factor: 1.817

5. The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: a double-blind, randomized control trial.

Authors: Gerald T Mangine; Adam M Gonzalez; Adam J Wells; William P McCormack; Maren S Fragala; Jeffrey R Stout; Jay R Hoffman
Journal: Lipids Health Dis Date: 2012-10-04 Impact factor: 3.876

5 in total